PURPOSE: To enhance the clinician's competence in interpretation of research studies related to use of honey for wound healing.
TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care.
OBJECTIVES: After participating in this educational activity, the participant should be better able to:
1. Relate the wound healing process to the antibiotic and anti-inflammatory mechanisms of honey.
2. Apply published study findings comparing honey to conventional dressings in clinical scenarios.
The therapeutic use of honey in wound care has been used since ancient times. Honey has been shown to have antibacterial properties in vitro and animal studies have demonstrated accelerated wound healing with the use of honey. In human trials, there is currently not enough strong evidence to fully support the use of honey in wound care; however, use in minor burns and prevention of radiation mucositis appear to be 2 areas where honey shows therapeutic promise.
This continuing education activity will help clinicians to better understand the inherent complexities of the clinical use of medical-grade honey, to consider the paucity of the strength-of-evidence ratings to support the use of time-honored remedies, and to select clinical entities in patients who may benefit from treatment with medical-grade honey.
Jason J. Song, MD, PhD • National Institutes of Health T32 Postdoctoral Fellow • Department of Physical Medicine and Rehabilitation, Hospital of the University of Pennsylvania • Philadelphia, Pennsylvania
Richard Salcido, MD • William Erdman Professor and Chair • Department of Physical Medicine and Rehabilitation • University of Pennsylvania School of Medicine • Director • University of Pennsylvania Health System Rehabilitation Services • Philadelphia, Pennsylvania
All authors and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.
This work was supported by NIH T32 Fellowship grant 5-T32-HD-007425 in the Department of Physical Medicine and Rehabilitation, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least 13 of the 18 questions correctly.
This continuing educational activity will expire for physicians on January 31, 2012.
A wound can result from either an external or an internal insult. Many acute wounds are caused by external insults, such as mechanical insults, thermal radiation, ultraviolet radiation, or radiation (gamma radiation) therapy. Chronic wounds (leg ulcers, diabetic ulcer, pressure ulcers), on the other hand, are largely caused by an internal insult in the form of circulatory compromise. Inadequate circulation robs tissue of necessary nutrients and potentiates proinflammatory cytokines, leading to tissues necrosis.1
The process of wound healing is classically divided into 4 stages: hemostasis (seconds to minutes), inflammation (3-5 days), proliferation (4-14 days), and remodeling (8 days to 1 year). There is significant overlap of the aforementioned stages.2 After hemostasis is achieved, debris and bacteria are removed from the wound during the inflammatory phase. This is followed by blood vessel invasion and the regeneration of the connective tissue and epithelium, along with wound contraction, in the proliferation phase. During the final stage, the remodeling phase, collagen is rearranged along tension lines, and excess tissue is removed via apoptosis.3 Older patients, infection, and poor circulation are believed to hinder this healing process.1
The goal of wound care is to first remove the offending insult, then to provide the best possible environment to facilitate wound healing. Controlling the bacterial load of a wound is one of the most important aspects in ensuring an optimal healing environment. A bacterial level greater than 105 organisms per gram of wound tissue has been found to have a deleterious effect on wound healing in surgical and chronic wounds.4,5 Many topical products with various properties are currently being used with the intent of facilitating wound healing. Surprisingly, there is a lack of strong evidence to support the use of the majority of these products.6-9
By reading this article, the clinician will be better able to assess the inherent complexities of the clinical use of medical-grade honey, to evaluate the paucity of the strength-of-evidence ratings to support the use of time-honored remedies, and to select clinical entities in patients who may benefit from treatment with medical-grade honey, using the evidence indicators such as the Cochrane reviews. Consideration of the biochemical properties of honey and their discrete mechanisms of action on the wound and the bioenvironment of the wound and antibiotic and anti-inflammatory mechanisms will also be discussed.
RATIONALE FOR HONEY IN WOUND CARE
Honey has been a product that has received a growing amount of attention in wound care, especially in the care of burn wounds. Since ancient times, honey has been used by man for both food and medicine in various cultures.6 Perhaps the first mention of honey in wound care was in ancient Egypt between 2600 and 2200 BCE.6 Although the exact mechanism for the beneficial aspects of honey in wound healing is still unknown, research has focused on the antibacterial property of honey as a cause. Honey is hygroscopic from its high sugar content, meaning it has a dehydrating effect that is inhibitory for bacterial growth. Studies have demonstrated that the antibacterial properties of honey are more complex than just high sugar content alone.10 Honey contains glucose oxidase, an enzyme that converts glucose to hydrogen peroxide, which may contribute to some of its antibacterial properties.6,11,12 Furthermore, the antibacterial properties of honey appear to vary depending on the floral source. Honey derived from Leptospermum trees (manuka) or Echium vulgare bush (viper's bugloss) showed antibacterial properties independent of hydrogen peroxide.13 It is believed that another, yet undiscovered, component of honey is responsible for the antibacterial properties.
Different types of honey have been shown to have antibacterial activity against the following bacterial species in vitro: Alcaligenes faecalis, Citrobacter freundii, Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, Mycobacterium phlei, Salmonella california, Salmonella enteritidis, Salmonella typhimurium, Shigella sonnei, Staphylococcus aureus, and Staphylococcus epidermidis. Interestingly, Serratia marcescens and the yeast Candida albicans were not inhibited by honey.14 In addition, manuka honey has also been shown to have an inhibitory effect on Pseudomonas aeruginosa, methicillin-resistant S aureus (MRSA), and vancomycin-resistant enterococcus species.15,16 In a recent report, ulmo honey showed superior anti-MRSA property compared with manuka honey.17 Lastly, honey displayed mixed antifungal activity.14,18
Animal studies have demonstrated, at the histological level, that honey accelerated wound healing. In rabbits with cutaneous wounds, honey was found to decrease edema, decrease inflammation, reduce necrosis, improve epithelialization, and improve wound contraction when the wound tissue was examined histologically.19 In mice, the use of honey also demonstrated accelerated wound healing on cutaneous wounds at the histological level.20
Clinical observations from human trials reported that honey-debrided wounds21,22 facilitated formation of granulating tissue,21-24 improved epithelialization,21,22 and reduced inflammation.22,25 This was consistent with what was reported in the animal study data previously discussed; however, clinical observation without the support of histological evidence is limited.
HONEY ON ACUTE WOUNDS
Although animal studies report accelerated healing time with the use of medical-grade honey,19,20,26 results in humans have been varied. Recently, 3 small (n = 40, each study) randomized, single-blind (examiner) controlled trial27-29 and 1 small (n = 40) randomized, nonblinded controlled trial30 demonstrated that honey may have some protective effects against radiation-induced mucositis in head and neck cancer patients undergoing therapy.
In a randomized, double-blind, controlled trial, honey dressing showed no difference in healing time compared with hydrogel dressings in patients who sustained abrasions or minor lacerations.31 In a randomized, double-blind controlled trial32 and a randomized single-blind controlled trial,33 patients who sustained toenail avulsions showed no differences in mean healing times when honey was compared with paraffin gauze and iodoform gauze, respectively. A meta-analysis of these 3 studies confirmed no statistical difference in mean time to healing between honey and conventional dressing in these minor acute wounds.6
In several randomized controlled trials, using honey on minor burns (superficial to partial-thickness burns) shows accelerated healing time compared with conventional dressings, such as silver sulfadiazine dressing25,34-36 and transparent polyurethane film dressing.23Figure 1 shows an example of superficial partial-thickness burns (not treated with honey). In addition, honey was found to be superior to nonconventional dressings, such as potato peels37 and amniotic membrane.38 However, the strength of these studies has been questioned because of the absence of the description of how randomization was achieved.6,39 Meta-analyses of these trials showed the use of honey to accelerate healing of minor burns compared with the previously mentioned comparators.6,39,40 In moderate burns (partial-thickness to full-thickness burns), a randomized controlled trial reported that early excision was superior to honey dressing.41 However, this study also failed to clearly state the method of randomization, which also raises questions on the strength of the study. Clinicians must consider the available evidence when selecting dressings for burn wounds.
HONEY ON CHRONIC WOUNDS
As stated earlier, many chronic wounds have their origins from circulatory compromise. Because topical agents do not adequately address the underlying circulatory compromise, it is not surprising that there is little evidence that supports the use of many products currently used.
Two randomized, open-label, controlled trials were reported on the use of honey on venous leg ulcers. In the larger study, honey-impregnated dressing did not significantly improve venous leg ulcers compared with conventional dressing at 12 weeks.42 Compression was used in both groups. In the second trial, honey dressing was compared with hydrogel in sloughy venous ulcers. At 12 weeks, honey was found to have a slightly higher rate of healing (44%) versus hydrogel (33%).43 The method of randomization was reported in both studies. A meta-analysis based on these 2 studies concluded that there is no statistical difference in healing between honey and conventional dressing in venous leg ulcers.6
In a poor-quality randomized controlled trial, honey dressing compared with saline-soaked dressing was found to accelerate healing in Stages I and II pressure ulcers.44 In another, poor-quality trial, honey was found to accelerate healing in Stage II or III pressure ulcers.45 In yet another randomized controlled trial of poor quality, honey dressing was found to be equivocal to iodine dressing in Wagner type II diabetic foot ulcers.46 The method of randomization was not described for any of these previously mentioned studies, which raises questions on their strength.
There is a paucity of strong evidence to support the use of many topical agents and dressings currently used in wound care. In systematic reviews, there was not enough evidence to support the use of the following: silver-containing dressing to promote wound healing,47,48 topical agents or dressings to promote healing in arterial ulcers,9 topical agents or dressings in minor burns to promote healing (superficial to partial-thickness burns),7 systemic or topical antibiotics in venous ulcers to promote healing,8 and topical agents or dressing in promoting postoperative wound healing by secondary intention.49 Failure to report the method of allocation concealment, failure to blind participants and/or outcome assessors, and inadequate follow-up were cited as limiting the strength of the randomized controlled trial.7-9,47
Despite some evidence that medical-grade honey may be beneficial in superficial and partial-thickness burns, many randomized controlled trials failed to report the method of randomization, which limited their strength.6,39,40 In addition,many of these trials were performed by the same researcher.23-25,36-38,41 In several trials on minor burn wounds,the use of honey was compared with silver sulfadiazine.24,25,34-36 Although silver dressings are currently used in burn wound care owing to its antibacterial properties, there is little support that silver is effective in promoting wound healing.47,48 Furthermore, several poor-quality studies reported that silver sulfadiazine may delay wound healing, putting in question its use as a suitable comparator.7 Although the evidence is poor, owing to the potential for silver sulfadiazine dressing to artificially skew results in favor of honey, future studies should exercise caution when considering using silver sulfadiazine as a comparator.
The antibacterial property of honey has been the focus regarding its use in wound healing; however, it is important to realize that honey is not a substitute for antibiotics. The current standard of care dictates that unless the wound is infected, prophylactic use of antibiotics is not recommended. There is little support that prophylactic antibiotics correlates with accelerated healing.8 For this reason, the antibacterial property alone may not explain the beneficial effects. Further in vitro studies and animal research need to be done to identify other components of honey involved in antibacterial, debriding, and anti-inflammatory properties. This may shed more light for the reason behind the variation between the different types of honey and may lead to the standardization of the type of honey used in therapy.
There are some promising results with the use of honey in minor burns and protection from radiation mucositis. However, large, multicenter, randomized controlled trials with at least single blinding (examiner) are needed prior to clinical recommendations being given. In addition, these studies should clearly indicate the method of allocation concealment and have adequate follow-up time.
After reading this article, the clinician should be better able to assess the inherent complexities of the clinical use of medical-grade honey, to evaluate the paucity of the strength-of-evidence ratings to support the use of time-honored remedies, and to select clinical entities in patients who may benefit from treatment with medical-grade honey, using the evidence indicators such as the Cochrane reviews.
1. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004;187(5A):65S-70S.
2. Janis JE, Kwon RK, Lalonde DH. A practical guide to wound healing. Plast Reconstr Surg 2010;125(6):230e-44e.
3. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998;176(2A Suppl):26S-38S.
4. Robson MC, Heggers JP. Delayed wound closure based on bacterial counts. J Surg Oncol 1970;2:379-83.
5. Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997;77:637-50.
6. Jull AB, Rodgers A, Walker N. Honey as a topical treatment for wounds. Cochrane Database Syst Rev 2008(4):CD005083.
7. Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev 2008(4):CD002106.
8. O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2010(1):CD003557.
9. Nelson EA, Bradley MD. Dressings and topical agents for arterial leg ulcers. Cochrane Database Syst Rev 2007(1):CD001836.
10. French VM, Cooper RA, Molan PC. The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 2005;56:228-31.
11. Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P. Medical honey for wound care-still the `latest resort'? Evid Based Complement Alternat Med 2009;6:165-73.
12. Langemo DK, Hanson D, Anderson J, Thompson P, Hunter S. Use of honey for wound healing. Adv Skin Wound Care 2009;22:113-8.
13. Allen KL, Molan PC, Reid GM. A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 1991;43:817-22.
14. Lusby PE, Coombes AL, Wilkinson JM. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 2005;36:464-7.
15. Cooper RA, Halas E, Molan PC. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 2002;23:366-70.
16. Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 2002;93:857-63.
17. Sherlock O, Dolan A, Athman R, et al. Comparison of the antimicrobial activity of Ulmo honey from Chile and Manuka honey against methicillin-resistant Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. BMC Complement Altern Med 2010;10:47.
18. Irish J, Carter DA, Shokohi T, Blair SE. Honey has an antifungal effect against Candida species. Med Mycol 2006;44:289-91.
19. Oryan A, Zaker SR. Effects of topical application of honey on cutaneous wound healing in rabbits. Zentralbl Veterinarmed A 1998;45:181-8.
20. Bergman A, Yanai J, Weiss J, Bell D, David MP. Acceleration of wound healing by topical application of honey. An animal model. Am J Surg 1983;145:374-6.
21. Efem SE. Clinical observations on the wound healing properties of honey. Br J Surg 1988;75:679-81.
22. Molan PC. Re-introducing honey in the management of wounds and ulcers-theory and practice. Ostomy Wound Manage 2002;48(11):28-40.
23. Subrahmanyam M. Honey impregnated gauze versus polyurethane film (OpSite) in the treatment of burns-a prospective randomised study. Br J Plast Surg 1993;46:322-3.
24. Subrahmanyam M. Topical application of honey in treatment of burns. Br J Surg 1991;78:497-8.
25. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns 1998;24:157-61.
26. Saber A. Effect of honey versus intergel in intraperitoneal adhesion prevention and colonic anastomotic healing: a randomized controlled study in rats. Int J Surg 2010;8:121-7.
27. Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer 2003;11:242-8.
28. Motallebnejad M, Akram S, Moghadamnia A, Moulana Z, Omidi S. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. J Contemp Dent Pract 2008;9(3):40-7.
29. Khanal B, Baliga M, Uppal N. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. Int J Oral Maxillofac Surg 2010;Sep 8.
30. Rashad UM, Al-Gezawy SM, El-Gezawy E, Azzaz AN. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol Otol 2009;123:223-8.
31. Ingle R, Levin J, Polinder K. Wound healing with honey-a randomised controlled trial. S Afr Med J 2006;96:831-5.
32. McIntosh CD, Thomson CE. Honey dressing versus paraffin tulle gras following toenail surgery. J Wound Care 2006;15:133-6.
33. Marshall C, Queen J, Manjooran J. Honey vs povidine iodine following toenail surgery. Wounds 2005;1(1):10-8.
34. Mashhood AA, Khan TA, Sami AN. Honey compared with 1% silver sulfadiazine cream in the treatment of superficial and partial thickness burns. J Pak Assoc Dermatol 2006;16:14-9.
35. Bangroo AK, Katri R, Chauhan S. Honey dressing in pediatric burns. J Indian Assoc Pediatr Surg 2005;10:172-5.
36. Subrahmanyam M, Sahapure AG, Nagane NS, Bhagwat VR, Ganu JV. Effects of topical application of honey on burn wound healing. Ann Burns Fire Disasters 2001;14(3).
37. Subrahmanyam M. Honey dressing versus boiled potato peel in the treatment of burns: a prospective randomized study. Burns 1996;22:491-3.
38. Subrahmanyam M. Honey-impregnated gauze versus amniotic membrane in the treatment of burns. Burns 1994;20:331-3.
39. Wijesinghe M, Weatherall M, Perrin K, Beasley R. Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J 2009;122(1295):47-60.
40. Moore OA, Smith LA, Campbell F, Seers K, McQuay HJ, Moore RA. Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med 2001;1:2.
41. Subrahmanyam M. Early tangential excision and skin grafting of moderate burns is superior to honey dressing: a prospective randomised trial. Burns 1999;25:729-31.
42. Jull A, Walker N, Parag V, Molan P, Rodgers A. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 2008;95:175-82.
43. Gethin G, Cowman S. Manuka honey vs. hydrogel-a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs 2009;18:466-74.
44. Weheida SM, Nagubib HH, El-Banna HM, Marzouk S. Comparing the effects of two dressing techniques on healing of low grade pressure ulcers. J Med Res Inst 1991;12:259-78.
45. Yapucu Gunes U, Eser I. Effectiveness of a honey dressing for healing pressure ulcers. J Wound Ostomy Continence Nurs 2007;34:184-90.
46. Shukrimi A, Sulaiman AR, Halim AY, Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia 2008;63(1):44-6.
47. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010;3:CD006478.
48. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006(1):CD005082.
49. Vermeulen H, Ubbink D, Goossens A, de Vos R, Legemate D. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst Rev 2004(2):CD003554.
For more than 57 additional continuing education articles related to Skin and Wound Care topics, go to NursingCenter.com/CE.
CONTINUING MEDICAL EDUCATION INFORMATION FOR PHYSICIANS
Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Lippincott Continuing Medical Education Institute, Inc., designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PROVIDER ACCREDITATION INFORMATION FOR NURSES
Lippincott Williams & Wilkins, publisher of the Advances in Skin & Wound Care journal, will award 2.0 contact hours for this continuing nursing education activity.
LWW is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing education activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
CONTINUING EDUCATION INSTRUCTIONS
* Read the article beginning on page 40.
* Take the test, recording your answers in the test answers section (Section B) of the CE enrollment form. Each question has only one correct answer.
* Complete registration information (Section A) and course evaluation (Section C).
* Mail completed test with registration fee to: Lippincott Williams & Wilkins, CE Group, 333 7th Avenue, 19th Floor, New York, NY 10001.
* Within 3 to 4 weeks after your CE enrollment form is received, you will be notified of your test results.
* If you pass, you will receive a certificate of earned contact hours and an answer key. Nurses who fail have the option of taking the test again at no additional cost. Only the first entry sent by physicians will be accepted for credit.
* A passing score for this test is 13 correct answers.
* Nurses: Need CE STAT? Visit http://www.nursingcenter.com for immediate results, other CE activities, and your personalized CE planner tool. No Internet access? Call 1-800-787-8985 for other rush service options.
* Questions? Contact Lippincott Williams & Wilkins: 1-800-787-8985.
Registration Deadline: January 31, 2013 (nurses); January 31, 2012 (physicians)
PAYMENT AND DISCOUNTS
* The registration fee for this test is $21.95 for nurses; $22 for physicians.
* Nurses: If you take two or more tests in any nursing journal published by LWW and send in your CE enrollment forms together by mail, you may deduct $0.95 from the price of each test. We offer special discounts for as few as six tests and institutional bulk discounts for multiple tests. Call 1-800-787-8985 for more information.